The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism

Thrombosis and Haemostasis

Volumn 109, Issue 1, 2013, Pages 79-84

  Reitter Pfoertner, Sylvia ^a   Waldhoer, Thomas ^a   Mayerhofer, Michaela ^a   Eigenbauer, Ernst ^a   Ay, Cihan ^a   Mannhalter, Christine ^a   Kyrle, Paul Alexander ^a   Pabinger, Ingrid ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

FVIII; Homocysteine; Mortality; Pulmonary embolism; Survival; Thrombosis; Venous thromboembolism

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE; PROTEIN C; PROTEIN S;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; LONG TERM SURVIVAL; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTITHROMBINS; AUSTRIA; BIOLOGICAL MARKERS; CAUSE OF DEATH; FACTOR V; FACTOR VIII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERHOMOCYSTEINEMIA; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVORS; THROMBOPHILIA; TIME FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 84872238600     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-05-0361     Document Type: Article

References (29)

1. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5: 692-699.
2. Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159: 445-453.
3. Anderson FA, Jr., Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938.
4. Schulman S, Lindmarker P, Holmstrom M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 4: 734-742.
5. Garcia-Fuster MJ, Forner MJ, Fernandez C, et al. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol Haemost Thromb 2005; 34: 6-12.
6. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
7. Reitter SE, Waldhoer T, Mayerhofer M, et al. Long-term survival of patients with a history of venous thromboembolism. Ann Hematol 2011; 90: 585-94.
8. Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol 1981; 10: 369-390.
9. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
10. Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-1373.
11. Schwarz HP, Fischer M, Hopmeier P, et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-1300.
12. Koster T, Blann AD, Briet E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-155.
13. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762.
14. Kyrle PA, Minar E, Bialonczyk C, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350: 2558-2563.
15. Eichinger S, Kyrle PA. Duration of anticoagulation after initial idiopathic venous thrombosis--the swinging pendulum: risk assessment to predict recurrence. J Thromb Haemost 2009; 7 (Suppl 1): 291-295.
16. Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. J Am Med Assoc 2005; 293: 2352-2361.
17. Rosendaal FR, Heijboer H. Mortality related to thrombosis in congenital antithrombin III deficiency. Lancet 1991; 337: 1545.
18. van Boven HH, Olds RJ, Thein SL, et al. Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families. Blood 1994; 84: 4209-4213.
19. Allaart CF, Rosendaal FR, Noteboom WM, et al. Survival in families with hereditary protein C deficiency, 1820 to 1993. Br Med J 1995; 311: 910-913.
20. Hille ET, Westendorp RG, Vandenbroucke JP, et al. Mortality and causes of death in families with the factor V Leiden mutation (resistance to activated protein C). Blood 1997; 89: 1963-1967.
21. Pabinger I, Vossen CY, Lang J, et al. Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost 2012; 10: 217-222.
22. Kovar FM, Marsik CL, Joukhadar C, et al. Coagulation factor VIII levels are associated with long-term survival-interactions with gender in a large hospitalbased cohort. Wien Klin Wochenschr 2010; 122: 334-340.
23. Statistics Austria. http://www.statistik.at/web_en. 2010.
24. Pabinger I, Grafenhofer H, Kaider A, et al. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol 2001; 21: 874-879.
25. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343: 457-462.
26. Kaplan EL MP. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
27. Flinterman LE, van Hylckama Vlieg A, Cannegieter SC, et al. Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med 2012; 9: e1001155.
28. Bots ML, Launer LJ, Lindemans J, et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 1999; 159: 38-44.
29. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-e494S.